sábado, 9 de abril de 2022

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario